Phesgo has been funded for eligible patients through the National Health Service since 10 February 2021. There are no restrictions on which providers can prescribe Phesgo. It is therefore for clinicians, in discussion with their patients, to decide on the most appropriate treatment.
Patients with breast cancer at Stepping Hill Hospital are clinically managed by the Christie Hospital NHS Foundation Trust. The Trust has agreed to use Phesgo. Patients at the hospital should therefore begin receiving this treatment in the near future.